$ARX

ONeill Francis James sold $3.1M of ARX (indirect holdings)

ONeill Francis James (Co-Founder, Chief U/W Officer) sold 215,114 indirectly-held shares of Accelerant Holdings (ARX) at an average of $14.60 ($14.56–$14.63, $3.14M total) across 2 trades over 2026-07-27 to 2026-07-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · ONeill Francis James
Published Jul 29, 2026, 10:25 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 10:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ARX
Neutral
medium confidence
Mentioned
$ARX
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARXNeutralLow
01

Why it matters

The newest concrete fact is the disclosed sale size ($3.14M) and the fact it was executed across two open-market trades at $14.5580 to $14.6308 per share.

02

Market read

Traders may monitor ARX for any follow-on insider activity, but the filing alone does not introduce new fundamentals.

03

What to watch

Indirect holdings and pre-arranged timing can mask the true motivation; without context on total compensation, tax events, or prior sale cadence, signal quality is limited.

Relevance 5/10Novelty 3/10Timing: after-hours, filed 2026-07-29 for trades dated 2026-07-27 to 2026-07-28

Background

The article is an SEC Form 4 insider transaction disclosure for Accelerant Holdings (ARX) by ONeill Francis James, listed as co-founder and Chief U/W Officer, with an explicit 10b5-1 plan.

Company-level read

Ticker impact

$ARXNeutralMedium confidence
Context

SEC Form 4 shows co-founder sold 215,114 shares of ARX in open-market trades for about $3.14M under a 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The filing is a primary-source insider transaction with defined trade dates and a stated 10b5-1 plan, reducing the likelihood of an information leak. The article provides no accompanying operational or financial catalyst.

Market effects

No sector read-through; this is company-specific insider liquidity activity.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity or tax-related execution under a 10b5-1 plan, so it may not reflect bearish fundamentals.

Key entities

  • Accelerant Holdings

    Subject of the Form 4 insider transaction disclosure.

  • ONeill Francis James

    Co-founder and Chief U/W Officer who sold ARX shares via a 10b5-1 plan.

Related articles

$ARXMed

ARX: Q2 2026 delivered robust operational and financial results, with the Shell acquisition progressing

Less than 1 min read Q2 2026 saw strong production growth and higher realized prices, driving a 20% year-over-year increase in funds from operations and a 94% rise in free funds flow per share. Net income declined 9% per share due to lower risk management gains and higher costs. The pending $22 billion Shell acquisition remains on track. Original document: ARC Resources Ltd. [ARX] Interim report — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies.

$ARXMed

ARX: Q2 2026 delivered robust production and cash flow as the $22B Shell acquisition advances

Less than 1 min read Q2 2026 saw 9% year-over-year production growth and strong cash flow, with $816 million in funds from operations and $349 million in free funds flow. The $22 billion Shell acquisition is progressing, with closing expected in Q3 2026. Original document: ARC Resources Ltd. [ARX] Earnings Release — Jul. 30 2026 Disclaimer This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

$ARXMed

Accelerant Holdings Stock Rises 10%

Accelerant Holdings (ARX) shares rose 9.73% to $12.86 on Wednesday after the company said it expanded a partnership with Incline P&C Group. Effective July 1, 2026, Incline will act as a fronting carrier for over $500 million in annual gross written premiums across Accelerant’s U.S. commercial specialty insurance portfolio.

$ARXMedAI 8/10

Oil Volatility Is Back: 3 Canadian Stocks to Buy Now

The article says oil and gas prices remain volatile and highlights three Canadian energy stocks. Tourmaline Oil (TOU) reported record Q1 production and expects higher free cash flow in 2026-27, planning a $0.50 quarterly base dividend (yield ~3.1%). Birchcliff (BIR) reported strong Q1 2026 results and a $0.03 quarterly dividend. ARC Resources (ARX) reported Q1 2026 net income of $584m ($1.03/share) and agreed to be acquired by Shell in a ~$16.4bn deal including debt.